Cover Image

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Seung Hwan Han,1 Gyu Chul Oh,2 Hyuck Moon Kwon,3 Chang Gyu Park,4 In Jai Kim,5 Gyo-Seung Hwang,6 Byung Su Yoo,7 Seong Hoon Park,8 Kwang Je Lee,9 Hyo-soo Kim21Division of Cardiology, Department of Internal Medicine, Gachon University College of Medicine, Gil Hospital, Incheon, Republic of Korea; 2Div...

Full description

Saved in:

Bibliographic Details
Main Authors:	Han SH (Author), Oh GC (Author), Kwon HM (Author), Park CG (Author), Kim IJ (Author), Hwang GS (Author), Yoo BS (Author), Park SH (Author), Lee KJ (Author), Kim HS (Author)
Format:	Book
Published:	Dove Medical Press, 2018-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito®) in Korean adults with hypertension and hypercholesterolemia
by: Ihm SH, et al.
Published: (2019)

Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization
by: Alderfer J, et al.
Published: (2022)

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
by: Zhao XY, et al.
Published: (2013)

Evaluating the potential implications of canadian front-of-pack labelling regulations in generic and branded food composition databases
by: Christine Mulligan, et al.
Published: (2022)

An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease
by: Mosaburo Kainuma, et al.
Published: (2022)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
by: Park JS, et al.
Published: (2016)

IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015)

IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015)

Generic Drugs or Branded Generics, Which One You Prefer to Prescribe?
by: Manjunath Premanath, et al.
Published: (2024)

Generic Tacrolimus (Tacrobell®) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation
by: Kim JM, et al.
Published: (2019)

Physicochemical stability of three generic brands of metformin in solution
by: Radamés Alemón-Medina, et al.
Published: (2014)

Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial
by: Han N, et al.
Published: (2017)

HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets
by: Emanuela Scudellaro, et al.
Published: (2020)

Comparative study of different meloxicam generic products with the brand product
by: Myasar Al-kotaji
Published: (2019)

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension
by: Shin MS, et al.
Published: (2016)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
by: Amir Hashemi-Meshkini, et al.
Published: (2014)

Comparison of Generic (Rolexan) and Brand (Clexan) Forms of Enoxaparin in Critically Ill Patients: A Cross Over, Open Label, Randomized Prospective Clinical Trial
by: Shadi Ziaie, et al.
Published: (2020)

Pharmacokinetic Drug Interaction Between Amlodipine and Tadalafil: An Open-Label, Randomized, Multiple-Dose Crossover Study in Healthy Male Volunteers
by: Kim H, et al.
Published: (2022)

Analyzing generic and branded substitution patterns in the Netherlands using prescription data
by: Postma Maarten J, et al.
Published: (2011)

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
by: Ping Yang, et al.
Published: (2021)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
by: Bosak M, et al.
Published: (2017)

Effect of Irbesartan on Chemerin in the Renal Tissues of Diabetic Rats
by: Qiu-Xia Yu, et al.
Published: (2015)

Long-term use and tolerability of irbesartan for control of hypertension
by: Forni V, et al.
Published: (2011)

Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers
by: Kim YH, et al.
Published: (2015)

Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs
by: Yuki Ito, et al.
Published: (2019)

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)
by: Chung WB, et al.
Published: (2020)

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
by: Ochi N, et al.
Published: (2014)

An In Vitro Aerosolization Efficiency Comparison of Generic and Branded Salbutamol Metered Dose Inhalers
by: Sara Rahimkhani, Saeed Ghanbarzadeh, Ali Nokhodchi, Hamed Hamishehkar
Published: (2017)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017)

Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
by: Lee MH, et al.
Published: (2023)

Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation
by: Chen G, et al.
Published: (2024)

Clinical Equivalence between Generic Versus Branded Antibiotics: Systematic Review and Meta-Analysis
by: André Cotia, et al.
Published: (2023)

Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
by: Danah ALRabeeah, et al.
Published: (2023)

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
by: Malvankar-Mehta MS, et al.
Published: (2019)

Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
by: Del Tacca M, et al.
Published: (2013)

CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION
by: N. A. Belolipetskiy, et al.
Published: (2015)

CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION
by: N. A. Belolipetskiy, et al.
Published: (2015)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
by: Nakamura M, et al.
Published: (2014)

Concentration-Dependent Inhibitory Effect of Irbesartan on Renal Uric Acid Transporters
by: Makiko Nakamura, et al.
Published: (2010)